Correction: Anti-phospholipase A2 receptor antibody levels at diagnosis predicts outcome of TAC-based treatment for idiopathic membranous nephropathy patients
Crossref DOI link: https://doi.org/10.1186/s12882-022-02950-0
Published Online: 2022-09-26
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Bihua
Zhu, Zhidan
Huang, Feng
Huang, Haowen
Tu, Luxia
Wang, Ying
Zheng, Linfeng
Zhou, Jing
Wei, Xin
Text and Data Mining valid from 2022-09-26
Version of Record valid from 2022-09-26
Article History
First Online: 26 September 2022